Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Protalex completes preclinical studies with new arthritis pharmaceutical

Oct. 9, 2001

Inhibitors of MMP and/or TNF-alpha reported in patent by Fujisawa

Oct. 8, 2001

Etoricoxib improves quality-of-life measures in osteoarthritis patients

Oct. 8, 2001

Chondrocyte damage induced by proinflammatory cytokine attenuated by PBN

Oct. 8, 2001

Experimental dog model of osteoarthritis used to evaluate therapeutic effects of ML-3000

Oct. 8, 2001

Safer NSAIDs designed by linking ibuprofen to furoxan moieties

Oct. 8, 2001

Chondroprotective anthraquinones with potential in osteoarthritis

Oct. 5, 2001

GSK develops highly potent and selective COX-2 inhibitors

Oct. 4, 2001

Human monoclonal antibody targeting IL-15 advances to clinical trials in RA patients

Oct. 4, 2001

Marine sponge-derived compound with antiinflammatory properties

Oct. 4, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...